Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-8.70%
↓ 144% below average
Average (39q)
19.74%
Historical baseline
Range
High:251.79%
Low:-98.42%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -8.70% |
| Q2 2025 | 17.07% |
| Q1 2025 | -12.42% |
| Q4 2024 | -39.49% |
| Q3 2024 | -54.61% |
| Q2 2024 | 251.79% |
| Q1 2024 | 14.86% |
| Q4 2023 | -13.79% |
| Q3 2023 | 108.36% |
| Q2 2023 | -98.42% |
| Q1 2023 | 32.97% |
| Q4 2022 | 196.08% |
| Q3 2022 | -19.24% |
| Q2 2022 | 0.73% |
| Q1 2022 | 7.88% |
| Q4 2021 | 19.99% |
| Q3 2021 | 6.06% |
| Q2 2021 | 20.37% |
| Q1 2021 | -29.91% |
| Q4 2020 | 110.32% |
| Q3 2020 | 38.30% |
| Q2 2020 | 117.30% |
| Q1 2020 | -10.24% |
| Q4 2019 | 15.36% |
| Q3 2019 | -13.77% |
| Q2 2019 | 7.03% |
| Q1 2019 | 58.46% |
| Q4 2018 | 61.89% |
| Q3 2018 | -0.10% |
| Q2 2018 | 0.10% |
| Q1 2018 | -0.10% |
| Q4 2017 | 0.10% |
| Q3 2017 | 0.00% |
| Q2 2017 | -0.10% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.10% |
| Q3 2016 | -0.10% |
| Q2 2016 | -22.31% |
| Q1 2016 | 22.86% |
| Q4 2015 | 4.87% |